How this startup uses blockchain to issue 'tamperproof' Covid-19 test results
Miami-based diagnostic lab GenoSur is teaming up with blockchain biometric startup GenoBank.io to protect Covid-19 test results from fraud. The partnership will enable GenoSur to certify the results of Covid-19 tests using blockchain technology and cryptographic signatures, said Head of Business Development Camilo Padron. Instead of issuing PDF results that can be easily manipulated on platforms like Photoshop, the collaboration will create Covid-19 negative test certifications stored on a public…
This study aimed to understand the extent to which cannabis-related risk perception and COVID-19-related health worries were associated with the reported reduction in sharing cannabis smoking products to mitigate the risk of the coronavirus transmission or infection. This association was tested in two different periods in terms of toughness of national lockdown policy imposed in the first months of the pandemic in Israel. The study population included adult recreational cannabis users who completed one of the two online cross-sectional surveys dedicated to COVID-19 and the cannabis use situation in Israel in the first h...
“Last March, I was working in a small primary care practice on the west side of Denver. COVID-19 came to town. On Thursday, March 12, we were told the schools would be closing. On Friday, we were told that clinic staff had to wear masks — and the clinic had to start testing patients forRead more …I was thinking about retiring, and COVID-19 gave me a push [PODCAST] originally appeared inKevinMD.com.
Both Iterion and Moleculin are moving their drug candidates through the regulatory pipeline.
The U.S. Food and Drug Administration has given the O.K. to Covid-19 vaccine "booster" shots made by Cambridge biotech Moderna Inc. Moderna (Nasdaq: MRNA) is now able to make and distribute boosters — third shots identical to each of the first two in the series, but half the amount — for patients 65 and older, adults with underlying medical conditions and adults who are at a high risk for Covid-19 because of their occupati ons or time in institutional settings. The decision comes a few days…
The foundation has funded $1.9 billion in pandemic-related responses. Its latest pledge is to accelerate access for an experimental antiviral treatment for Covid-19 infections.
As the number of Americans getting COVID-19 vaccines has risen, there is a heightened push to provide booster shots to some vaccinated persons to ensure that their immunity continues.Medscape Reader Polls
In stable patients with COVID-19, use of aspirin or apixaban did not reduce the rate of the composite of all-cause mortality, thromboembolism, MI, stroke, or hospitalization in the ACTIV-4B trial.Medscape Medical News
Even as metro Milwaukee ’s largest private sector employer Advocate Aurora Health said 99% of its employees complied with its Covid-19 vaccine policy, another major area employer, GE Healthcare, said all of its employees must get vaccinated by Dec. 8.